Study guide
13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow
Certified Pulmonary Function Technologist CPFT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Overview & NBRC Certification Requirements
1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing
2 Chapter 2: Spirometry Equipment & Sensors
2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification
3 Chapter 3: Body Plethysmography & Hardware
3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography
4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control
4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices
5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria
5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops
6 Chapter 6: Lung Volume Determination Protocols
6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods
7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing
7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education
8 Chapter 8: Cardiopulmonary Exercise & ABG Testing
8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis
9 Chapter 9: Reference Values & PFT Calculations
9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations
10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation
10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols
11 Chapter 11: Artifact Recognition & Quality Assurance
11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance
12 Chapter 12: Documentation, Compliance, & Emergency Safety
12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab
13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data
13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management
13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow
Key Takeaways Explain This Topic AI
Respiratory muscle strength is Domain II task 17 and Domain III task 14, and the outline names MIP, MEP, and cough peak flow explicitly.
Maximal inspiratory pressure is measured from residual volume and maximal expiratory pressure from total lung capacity, each sustained for at least 1.5 seconds with the plateau value over 1 second reported.
The mouthpiece assembly must include a small leak of about 2 mm diameter and 20 to 30 mm length so that buccal muscles and glottic closure cannot generate a false pressure.
At least three maneuvers are performed and the two largest values should agree within about 10% or 10 cmH2O; the highest acceptable value is reported.
A cough peak flow below 270 L/min predicts ineffective secretion clearance during respiratory infection, and below 160 L/min indicates the need for assisted airway clearance.
Last updated: August 2026
13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow
The Detailed Content Outline names respiratory muscle strength (for example, MIP, MEP, cough peak flow) as procedure item 17 in Domain II and as data item 14 in Domain III. That places it under all six task verbs — select, perform, evaluate validity, calculate, evaluate reliability, and evaluate clinical implications. It is a small test with an outsized role in neuromuscular disease, where it detects weakness months before vital capacity falls below the lower limit of normal.
What the Measurements Represent
Test Measures Started From Primary Muscles
MIP (P Imax _{\text{Imax}} Imax , NIF) Maximal inspiratory pressure Residual volume Diaphragm, external intercostals, accessory inspiratory muscles
MEP (P Emax _{\text{Emax}} Emax ) Maximal expiratory pressure Total lung capacity Abdominal muscles, internal intercostals
- SNIP Sniff nasal inspiratory pressure FRC, through an occluded nostril Diaphragm, without a mouthpiece
- Cough peak flow Peak flow generated by a voluntary cough TLC Expiratory muscles plus glottic function
The starting lung volumes are not arbitrary. Inspiratory muscles are at their most favorable length–tension relationship at residual volume; expiratory muscles are at theirs at total lung capacity. Starting from the wrong volume systematically underestimates strength.
Equipment and the Critical Leak
The measuring system is an occluded mouthpiece assembly connected to an aneroid manometer or a pressure transducer capable of recording at least ± \pm ± 200 cmH 2 _2 2 O, with a rigid, non-collapsible circuit.
The single most testable equipment detail is the deliberate leak : the mouthpiece assembly must contain a small orifice, conventionally about 2 mm in diameter and 20–30 mm long . Its purpose is not comfort. Without it, a patient can:
generate a large negative mouth pressure by expanding the cheeks and using buccal muscles rather than the diaphragm, and
generate a large positive pressure by closing the glottis and compressing air in the mouth.
The leak is large enough to dissipate pressure created by the cheeks and mouth, but far too small to relieve pressure generated by the thorax over the 1–2 second measurement window. A flanged or scuba-type mouthpiece is preferred over a tube mouthpiece because it distributes lip pressure and prevents perioral leak in weak patients; a face mask is used when facial weakness prevents a seal.
Technique
MIP:
Seat the patient upright with a nose clip in place.
Coach a full, unforced exhalation to residual volume .
Occlude the mouthpiece and instruct a maximal inspiratory effort — "pull in as hard as you can and keep pulling" — sustained for at least 1.5 seconds .
Record the maximum pressure sustained over 1 second (the plateau), not the transient spike. A very brief spike is usually a mouth artifact.
MEP:
Coach a full inspiration to total lung capacity .
Occlude and instruct a maximal expiratory effort — "blow as hard as you can and keep blowing" — sustained for at least 1.5 seconds .
Support the cheeks with the hands or an assistant's hands to eliminate buccal contribution.
Number of efforts and repeatability: perform at least three acceptable maneuvers, with 30–60 seconds of rest between efforts. The two largest values should agree within about 10% or 10 cmH 2 _2 2 O , and the highest acceptable value is reported. Because both tests are highly effort- and learning-dependent, values often improve across the first several efforts; a rising series means coaching is still working and more efforts are warranted, up to the point of fatigue.
Reference Values and Thresholds
Reference equations vary widely between published sets, so laboratories should state which set they use. Commonly cited adult lower limits:
MIP: more negative than about − 80 -80 − 80 cmH 2 _2 2 O in men and − 70 -70 − 70 cmH 2 _2 2 O in women.
MEP: greater than about + 100 +100 + 100 cmH 2 _2 2 O in men and + 80 +80 + 80 cmH 2 _2 2 O in women.
Interpretive anchors:
A normal MIP effectively excludes clinically significant inspiratory muscle weakness. Its negative predictive value is its greatest strength.
A low MIP is far less specific, because submaximal effort, poor comprehension, and mouthpiece leak all lower it.
MIP less negative than − 30 -30 − 30 cmH 2 _2 2 O is associated with hypercapnic respiratory failure risk and nocturnal hypoventilation.
Reduced MEP predicts an ineffective cough, retained secretions, and a rising RV/TLC ratio, because weak expiratory muscles cannot compress the thorax toward true residual volume.
SNIP and the Supine Vital Capacity
Sniff nasal inspiratory pressure (SNIP) measures pressure in an occluded nostril during a short, sharp maximal sniff from FRC. It requires no mouthpiece, so it avoids perioral leak entirely and is often easier for patients with facial or bulbar weakness. It underestimates in nasal obstruction. SNIP and MIP are complementary: if either is normal, significant inspiratory weakness is unlikely.
Supine vital capacity is the cheapest and most specific bedside test of diaphragm function. Lying supine displaces abdominal contents against the diaphragm; a healthy diaphragm compensates, a weak one does not.
Normal: VC falls less than 10% from upright to supine.
Fall of 10–20%: suggests diaphragm weakness.
Fall greater than 25–30%: strongly suggests bilateral diaphragm paralysis.
This is the same postural maneuver the content outline lists as spirometry item 2b (upright/supine), and it is the reason a technologist should never quietly perform a "supine because the patient was tired" spirometry without documenting position.
Cough Peak Flow
Cough peak flow (peak cough expiratory flow) is measured with a peak flow meter or pneumotachometer, through a mouthpiece or face mask, after a maximal inspiration to TLC followed by a maximal voluntary cough. Report the best of three efforts.
- Cough Peak Flow Clinical Implication
- > 270 L/min Adequate secretion clearance expected
160–270 L/min Marginal; clearance likely to fail during a respiratory infection, when secretions increase and muscle performance falls
< 160 L/min Ineffective cough; assisted clearance (manually assisted cough, mechanical insufflation-exsufflation) indicated
Cough peak flow integrates three things — an adequate inspiration, adequate expiratory muscle force, and normal glottic closure and release — so a low value in a patient with a preserved MEP should prompt evaluation of bulbar function.
Evaluating Validity: Falsely Strong and Falsely Weak
Finding Cause Recognition
Falsely strong MIP/MEP Buccal or glottic pressure generation with a blocked or absent leak Very brief spike without a sustained plateau; cheeks visibly bulging
Falsely weak Perioral leak, poor comprehension, submaximal effort, wrong starting lung volume Values rise steadily across efforts; audible leak; no plateau
Falsely weak Nose clip omitted (MIP) or displaced Air movement audible at the nose
Unreliable Fewer than three efforts, or a still-rising series Two largest values differ by more than 10% or 10 cmH 2 _2 2 O
Document the reference set used, the number of efforts, whether a plateau was achieved, the interface (mouthpiece versus mask), and patient position. Without those, a serial comparison across visits means nothing.